International Society for the Study of Emerging Drugs CIC
Registered name: INTERNATIONAL SOCIETY FOR THE STUDY OF EMERGING DRUGS CIC
International Society for the Study of Emerging Drugs CIC made £17.3k revenue and a £5.3k loss in the year to 31 Mar 2024.
International Society for the Study of Emerging Drugs CIC’s revenue grew 4% to £17.3k in the year to 31 Mar 2024, with a loss of £5.3k and 4 employees. The company is classified under “activities of other membership organizations” and is based in Chelmsford; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- Chelmsford, East of England
- Age
- 6 yrs · since 2020
- Type
- Community Interest Company
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Mar 2022 | 31 Mar 2023 | 31 Mar 2024 |
|---|---|---|---|
| Disclosure | No P&L | Full P&L | Full P&L |
| Profit & loss | |||
| Revenue (turnover) | — | £16.6k | £17.3k |
| Cost of sales | — | £4.4k | £23.4k |
| Gross profit | — | £12.2k | −£6k |
| Operating profit | — | £12.7k | −£6.5k |
| Profit before tax | — | £12.7k | −£6.5k |
| Profit after tax | — | £10.8k | −£5.3k |
| Profit (best available) | — | £10.8k | −£5.3k |
| Employees (average) | 0 | 4 | 4 |
| Ratios | |||
| Profit margin | — | 65.2% | −30.4% |
| Gross margin | — | 73.6% | −34.8% |
| Revenue per employee | — | £4.2k | £4.3k |
| Profit per employee | — | £2.7k | −£1.3k |
| Growth (year on year) | |||
| Revenue growth | — | — | ▲4.2% |
| Profit growth | — | — | ▼148.6% |
| Headcount growth | — | — | 0% |
| Balance sheet — indirect signals, not revenue | |||
| Cash at bank | £16.9k | £14k | £29.5k |
| Net assets | −£3.1k | £7.8k | £2.5k |
| Fixed assets | £0 | £0 | — |
| Current assets | £16.9k | £14k | £30.7k |
| Debtors | £0 | £0 | £1.2k |
| Deferred income | £0 | £0 | — |
| Source | FullAccounts · bulk data Dec 2023 | FullAccounts · bulk data Dec 2023 | FullAccounts · bulk data Dec 2024 |
How the business works
- Profit margin
- −30.4%
- Profit ÷ revenue.
- Gross margin
- −34.8%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £4.3k
- Revenue ÷ average employees.
- Profit per employee
- −£1.3k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 7.1%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▼68%
- Now £2.5k
- Cash at bank
- ▲111%
- Now £29.5k
- Headcount
- 0%
- Now 4
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Sources
Latest figures from FullAccounts for the year to 31 Mar 2024 (profit −£5.3k), from the Companies House accounts bulk data published Dec 2024. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.